FOCIS 2014 - 2018: The 14th through 18th Annual Meetings of the Federation of Cli
FOCIS 2014 - 2018:第 14 届至第 18 届气候变化联合会年会
基本信息
- 批准号:8874088
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-09 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Applied ResearchAsthmaAutoimmune DiseasesAutoimmune ProcessAwardBacterial InfectionsBasic ScienceBiotechnologyCellsClinicalClinical ImmunologyCommunicable DiseasesComplexCritical PathwaysCritiquesDevelopmentDiagnosisDisciplineDiseaseDrug IndustryEducationFacultyFeedbackFosteringGenerationsGenesGeneticGoalsGraft RejectionHIVHealthHost DefenseHumanHypersensitivityImmuneImmune systemImmunogeneticsImmunological DiagnosisImmunologyImmunotherapyIncubatorsIndividualInfectionInflammatoryInterdisciplinary EducationInterventionKnowledgeLaboratoriesLearningLifeLinkMalignant NeoplasmsOralOrganPlayPostdoctoral FellowRegulationResearchResearch PersonnelRoleScienceScientific Advances and AccomplishmentsScientistSocietiesStructureTechniquesTherapeuticTherapeutic InterventionTranslatingTranslationsTravelVaccinesVirusVirus DiseasesVisionVoiceWomanWorkabstractingbasebench to bedsideclinical applicationclinical practicecostimmune functionimmunoregulationimprovedinterdisciplinary approachinterdisciplinary collaborationinterestmedical specialtiesmeetingsmembermicrobialmultidisciplinarynovelnovel diagnosticsnovel therapeutic interventionpathogenpostersprogramssuccesstranslational approach
项目摘要
DESCRIPTION (provided by applicant): Understanding function and regulation of the immune system is critical for many diseases, including autoimmune diseases, cancer, allergy/asthma, infectious diseases, immune deficiency, and transplant rejection. To exploit scientific advances, two major barriers need to be overcome: The translation of basic findings into clinically and medically relevant contexts, and second, the exchange of findings in immunological sciences which unify these diverse diseases through multidisciplinary approaches cutting across traditional clinical boundaries. FOCIS, the Federation of Clinical Immunology Societies links 54 professional societies representing 60,000 professionals with the common vision of improving human health through immunology.
This meeting provides a scientific forum that fosters a cross-disciplinary approach required to understand and treat immune-based diseases. While clinicians necessarily remain linked to diseases associated with their own specialty, the immunological sciences underlying recent advances in diagnosing and treating these diverse diseases are multidisciplinary and cut across standard clinical boundaries. The goal of the meeting is to create a better understanding of the shared pathophysiological underpinnings of clinical immunology and the new therapeutic approaches suggested by these novel relationships, including the increasingly widespread use of biologics in therapy. FOCIS offers investigators and clinicians an opportunity to understand and translate breakthroughs in basic science and clinical applications from a variety of different fields.
The meeting is also an incubator for developing scientists and practitioners to meet with one another along with representatives of relevant biotechnology and pharmaceutical industry. Each day includes poster and oral abstract presentations to give young investigators the chance to have their work presented and critiqued. FOCIS takes a specific interest in the development of young investigators and provide travel awards to them to supplement their costs to attend the meeting.
By sharing discoveries with one another, delegates acquire new ideas for research and applied science from disciplines to which they would otherwise not be exposed at disease- or organ-specific meetings. The FOCIS meetings are an ideal forum for a diverse group of new investigators to learn about the different translational approaches that are bridging the basic immunology laboratories within clinical practice. Your support from 2009-2013 played a key role in bringing women, trainees, post-docs and junior faculty members to the FOCIS Annual Meeting. FOCIS is requesting continued support from 2014-2018 because interdisciplinary collaboration and education in translational immunology will continue to be an important factor in improving human health through immunology throughout the entire period.
描述(由申请人提供):了解免疫系统的功能和调节对于许多疾病至关重要,包括自身免疫性疾病、癌症、过敏/哮喘、传染病、免疫缺陷和移植排斥。为了利用科学进步,需要克服两个主要障碍:将基本发现转化为临床和医学相关背景,第二,通过跨越传统临床界限的多学科方法统一这些不同疾病的免疫学研究结果的交流。FOCIS是临床免疫学协会联合会,它将代表60,000名专业人员的54个专业协会联系在一起,共同愿景是通过免疫学改善人类健康。
本次会议提供了一个科学论坛,促进了解和治疗免疫性疾病所需的跨学科方法。虽然临床医生必然与自己的专业相关的疾病保持联系,但在诊断和治疗这些不同疾病方面的最新进展背后的免疫学科学是多学科的,并且跨越了标准的临床界限。会议的目标是更好地理解临床免疫学的共同病理生理学基础以及这些新关系所建议的新治疗方法,包括生物制剂在治疗中日益广泛的使用。FOCIS为研究人员和临床医生提供了一个机会,让他们了解和翻译来自各种不同领域的基础科学和临床应用的突破。
会议也是培养科学家和从业人员的孵化器,沿着相关生物技术和制药行业的代表。每一天都包括海报和口头摘要介绍,让年轻的研究人员有机会展示和评论他们的工作。FOCIS特别关注年轻调查员的发展,并向他们提供旅费,以补充他们参加会议的费用。
通过彼此分享发现,代表们从学科中获得了研究和应用科学的新想法,否则他们不会在疾病或器官特异性会议上接触到这些新想法。FOCIS会议是一个理想的论坛,让不同的新研究人员学习不同的翻译方法,这些方法在临床实践中桥接了基础免疫学实验室。您从2009年至2013年的支持发挥了关键作用,使妇女,学员,博士后和初级教师的FOCIS年会。FOCIS要求在2014-2018年期间继续提供支持,因为跨学科合作和转化免疫学教育将继续成为通过免疫学改善人类健康的重要因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William H Robinson其他文献
Immune tolerance of citrullinated peptides.
瓜氨酸肽的免疫耐受。
- DOI:
10.1038/s41584-024-01081-0 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
R. Thomas;William H Robinson - 通讯作者:
William H Robinson
Imatinib for the treatment of rheumatic diseases
伊马替尼用于治疗风湿性疾病
- DOI:
10.1038/ncprheum0465 - 发表时间:
2007-04-01 - 期刊:
- 影响因子:32.700
- 作者:
Ricardo T Paniagua;William H Robinson - 通讯作者:
William H Robinson
Human peptidome display
人类肽组展示
- DOI:
10.1038/nbt.1888 - 发表时间:
2011-06-07 - 期刊:
- 影响因子:41.700
- 作者:
William H Robinson;Lawrence Steinman - 通讯作者:
Lawrence Steinman
William H Robinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William H Robinson', 18)}}的其他基金
BCCMA: Targeting Osteoarthritis Pain and Progression: Proteomics, RNASeq & Immunostaining to elucidate the immune pathotypes of OA
BCCMA:针对骨关节炎疼痛和进展:蛋白质组学、RNASeq
- 批准号:
10590409 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Investigating the IL-4/13 Axis in Osteoarthritis
研究骨关节炎中的 IL-4/13 轴
- 批准号:
9891690 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Investigating the IL-4/13 Axis in Osteoarthritis
研究骨关节炎中的 IL-4/13 轴
- 批准号:
10092814 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Investigating the IL-4/13 Axis in Osteoarthritis
研究骨关节炎中的 IL-4/13 轴
- 批准号:
10438519 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Investigating the IL-4/13 Axis in Osteoarthritis
研究骨关节炎中的 IL-4/13 轴
- 批准号:
10553629 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Targeting Mast Cells in Post-Traumatic Joint Rehabilitation and Osteoarthritis
在创伤后关节康复和骨关节炎中靶向肥大细胞
- 批准号:
10025268 - 财政年份:2018
- 资助金额:
$ 2.5万 - 项目类别:
Targeting Mast Cells in Post-Traumatic Joint Rehabilitation and Osteoarthritis
在创伤后关节康复和骨关节炎中靶向肥大细胞
- 批准号:
10672163 - 财政年份:2018
- 资助金额:
$ 2.5万 - 项目类别:
Targeting Mast Cells in Post-Traumatic Joint Rehabilitation and Osteoarthritis
在创伤后关节康复和骨关节炎中靶向肥大细胞
- 批准号:
10284924 - 财政年份:2018
- 资助金额:
$ 2.5万 - 项目类别:
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
肺腺癌抗癌抗体反应的大规模表征
- 批准号:
8664101 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
- 批准号:
10637048 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别: